We hypothesized that exenatide would attenuate mitochondrial dysfunction by reducing hepatic lipid deposition, blunting oxidant stress and promoting insulin metabolic signaling in a high fat diet-induced model of obesity and insulin resistance.
It resensitizes cells to insulin signaling and is used to treat Type 2 diabetes. The rationale of this approach is that counteracting the insulin resistance that accompanies some cases of Alzheimer's disease might confer a therapeutic benefit (e.g. Talbot et al., 2012; Talbot, 2014).
Weight loss, especially android fat mass reduction, is related to insulin resistance improvement [20, 43]; the positive relationship between fat mass reduction and the decreases in FBG and HbA1c only with exenatide in the current study suggests a more prolonged beneficial effect of...
Type 2 diabetes is generally characterized by two principal abnormalities: insulin resistance and progressive failure of pancreatic -cell function that leads to inadequate insulin secretion. The current approach to the management of type 2 diabetes.
Medications such as metformin, exenatide and a class of drugs called the thiazolidinediones can help improve insulin resistance. These are approved in the treatment of type 2 diabetes but not for the treatment of insulin resistance alone.
Recent studies suggest that GLP-1-RAs act on liver and adipose tissue to reduce insulin resistance (IR). Thus, we evaluated the acute effects of exenatide (EX) on hepatic (Hep-IR) and adipose (Adipo-IR) insulin resistance and glucose uptake.
Insulin resistance and diabetes are related but not the same. If you have insulin resistance, your blood sugar is still within a normal range. Prediabetes usually happens to people who have some insulin resistance.
